SCHEMBL13309478

SCHEMBL13309478

CC(C)(C)OC(=O)N1CCCC(c2cc(Nc3ccc(-n4ccnc4)cc3)n3ncc(Br)c3n2)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR119 Q8TDV5 1/20 0.44
▸ PIK3CD O00329 1/20 0.43
▸ FPR2 P25090 2/20 0.39
▸ CDK4 P11802 1/20 0.39
▸ CCND1 P24385 1/20 0.39
▸ CCND2 P30279 1/20 0.39
▸ CCND3 P30281 1/20 0.39
▸ GSK3B P49841 3/20 0.38
▸ TRPV3 Q8NET8 1/20 0.38
▸ CHEK1 O14757 1/20 0.37
▸ JAK2 O60674 3/20 0.37
▸ JAK1 P23458 1/20 0.37
▸ USP30 Q70CQ3 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ EGFR P00533 1/20 0.36
▸ IGF1R P08069 1/20 0.36
▸ JAK3 P52333 2/20 0.35
▸ PTK2 Q05397 2/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ BTK Q06187 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11931565 0.88 CHEK1 (0.52) GPR119PIK3CDCHEK1
SCHEMBL14218799 0.87 CHEK1 (0.43) GPR119PIK3CDCDK4CCND1CCND2
SCHEMBL13309406 0.84 GPR119 (0.44) GPR119PIK3CDFPR2CDK4CCND1
SCHEMBL13309217 0.81 JAK2 (0.41) FPR2GSK3BTRPV3CHEK1JAK2
SCHEMBL11931591 0.78 CHEK1 (0.46) FPR2GSK3BTRPV3CHEK1JAK2
SCHEMBL14561895 0.78 ALDH1A1 (0.40) GPR119FPR2GSK3BTRPV3CHEK1
SCHEMBL14541613 0.78 TRPV3 (0.43) PIK3CDFPR2TRPV3CHEK1JAK2
SCHEMBL14541702 0.78 GSK3B (0.58) GSK3BCHEK1
SCHEMBL11931582 0.77 CHEK1 (0.56) CHEK1USP30
SCHEMBL14942244 0.77 CHEK1 (0.53) FPR2TRPV3CHEK1JAK2JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1934224-B1 PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS FOR THE TREATMENT OF CANCER SCHERING CORP (US) 2010-06-09 — — EP disclosed
US-7205308-B2 Trisubstituted 7-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors SCHERING CORPORATION (US) 2007-04-17 — — US disclosed
Send feedback